Patent · US Active

Inhibitory antibodies against MMP-14

US10975166B2 · kind B2 · utility

2Cited by

1References

9Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Xin Ge · Riverside, US
Dong Hyun Nam · Yongin-si, KR
Tyler Lopez · Winchester, US

Key dates

Filing date	Dec 18, 2018
Grant date	Apr 13, 2021
Priority date	—
Expiry date	Dec 18, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Certain embodiments of the invention provide an antibody, or a fragment thereof, comprising a heavy chain complementarity-determining region 3 (CDR-H3) having at least about 80% sequence identity to a sequence described herein, as well as methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.